KRISTY YENTES: Open Payments
NPI 1124381371 · FORT MYERS, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,218 in 62 payments from 21 companies in 2025. Trend: 2023 $127 · 2024 $555 · 2025 $1,218
Food & beverage: $1,218
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 10 | $214 |
| Lilly USA, LLC | 10 | $169 |
| Novo Nordisk Inc | 6 | $124 |
| PFIZER INC. | 6 | $108 |
| Novartis Pharmaceuticals Corporation | 3 | $64 |
| Xeris Pharmaceuticals, Inc. | 3 | $64 |
| ACADIA Pharmaceuticals Inc | 2 | $58 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $50 |
| Sumitomo Pharma America, Inc. | 3 | $49 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $40 |
Products named: QULIPTA, MOUNJARO, Ozempic, LEQVIO, GVOKE HYPOPEN, UBRELVY, JARDIANCE, DAYBUE.
Industry payments across FL — which companies pay providers there.
